List view / Grid view
Using chemical genetic screening and pre-clinical model studies, researchers have discovered that inducing ubiquitin-mediated degradation of mutant EZH2 could provide a more effective treatment strategy for haematologic malignancies.
A network of hospitals have systematically collected biopsies from metastatic cancer patients in order to create a global database...
11 July 2016 | By Victoria White, Digital Content Producer
Researchers from the University of Birmingham have revealed how a common condition called ‘MGUS’ can develop into myeloma...
6 May 2016 | By Victoria White, Digital Content Producer
The new animal model was generated when researchers crossed two genetically modified mice: mice lacking the Mef gene and mice with a Rad50 gene mutation...
27 January 2016 | By Victoria White
Myeloma UK and the SGC have entered into an open-access research partnership to discover drug targets for myeloma using structural biology and chemical proteomics...
